Regulatory Authority and Joint Study Group
- The revisions and updates follow a series of reviews and studies conducted jointly by the Bureau of Food and Drugs (BFAD) and the cosmetics industry.
- This indicates a cooperative approach integrating industry input with regulatory oversight.
Amendments to Previous Regulations
- Bureau Order No. 101-H, series of 1995, amends Sections III to VI of Memorandum Circular No. 19-A, series of 1992.
- These amendments reflect changes in the prescribed ingredients and substances after regulatory review.
Guidelines on Labeling of Cosmetics
- Alongside the updated ingredient lists, the BFAD adopted recommended guidelines on the labeling of cosmetics.
- These guidelines are formalized through Memorandum No. 21, series of 1995.
- Memorandum No. 21 is specifically addressed to BFAD personnel responsible for evaluating cosmetic claims, ensuring claims are substantiated and compliant.
Access to Documents
- Copies of Bureau Order No. 101-H and Memorandum No. 21 can be obtained from the BFAD Information Unit.
- This provision facilitates transparency and accessibility of regulatory standards.
Legal Authority and Adoption
- The circular itself was adopted on October 9, 1995.
- It is signed by Dr. Quintin L. Kintanar, Director of BFAD, conferring authoritative endorsement.
Key Legal Concepts
- The circular underscores the regulatory framework governing cosmetic ingredients and labeling under BFAD oversight.
- It highlights the dynamic nature of regulation, with periodic reviews and updates based on scientific and industry studies.
- It also exemplifies the institutional mechanism for ensuring consumer safety and product integrity through strict labeling and ingredient control.